US 12076409
Polymer-drug conjugates for combination anticancer therapy
granted A61KA61K31/4745A61K31/704
Quick answer
US patent 12076409 (Polymer-drug conjugates for combination anticancer therapy) held by The Regents of the University of California expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4745, A61K31/704, A61K31/7068, A61K47/61